Pennsylvania HB2545 mandates insurance coverage for vaginal estrogen to treat menopausal symptoms and prevent urinary tract infections.

HB2545, known as the Coverage for Vaginal Estrogen Act, requires health insurance policies in Pennsylvania to cover vaginal estrogen for treating menopausal symptoms and preventing urinary tract infections. This coverage must include all FDA-approved drugs, devices, and combination products for vaginal estrogen. The act applies to policies filed with the Insurance Department after its effective date and to those issued or renewed 180 days after the effective date. Coverage is subject to terms and conditions such as medical necessity, cost sharing, and utilization review.

Pennsylvania HB2545 mandates insurance coverage for vaginal estrogen to treat menopausal symptoms and prevent urinary tract infections.

HB2545, known as the Coverage for Vaginal Estrogen Act, requires health insurance policies in Pennsylvania to cover vaginal estrogen for treating menopausal symptoms and preventing urinary tract infections. This coverage must include all FDA-approved drugs, devices, and combination products for vaginal estrogen. The act applies to policies filed with the Insurance Department after its effective date and to those issued or renewed 180 days after the effective date. Coverage is subject to terms and conditions such as medical necessity, cost sharing, and utilization review.